• English

    Google Translate Disclaimer

    The Maryland Department of Information Technology (“DoIT”) offers translations of the content through Google Translate. Because Google Translate is an external website, DoIT does not control the quality or accuracy of translated content. All DoIT content is filtered through Google Translate which may result in unexpected and unpredictable degradation of portions of text, images and the general appearance on translated pages. Google Translate may maintain unique privacy and use policies. These policies are not controlled by DoIT and are not associated with DoIT’s privacy and use policies. After selecting a translation option, users will be notified that they are leaving DoIT’s website. Users should consult the original English content on DoIT’s website if there are any questions about the translated content.

    DoIT uses Google Translate to provide language translations of its content. Google Translate is a free, automated service that relies on data and technology to provide its translations. The Google Translate feature is provided for informational purposes only. Translations cannot be guaranteed as exact or without the inclusion of incorrect or inappropriate language. Google Translate is a third-party service and site users will be leaving DoIT to utilize translated content. As such, DoIT does not guarantee and does not accept responsibility for, the accuracy, reliability, or performance of this service nor the limitations provided by this service, such as the inability to translate specific files like PDFs and graphics (e.g. .jpgs, .gifs, etc.).

    DoIT provides Google Translate as an online tool for its users, but DoIT does not directly endorse the website or imply that it is the only solution available to users. All site visitors may choose to use alternate tools for their translation needs. Any individuals or parties that use DoIT content in translated form, whether by Google Translate or by any other translation services, do so at their own risk. DoIT is not liable for any loss or damages arising out of, or issues related to, the use of or reliance on translated content. DoIT assumes no liability for any site visitor’s activities in connection with use of the Google Translate functionality or content.

    The Google Translate service is a means by which DoIT offers translations of content and is meant solely for the convenience of non-English speaking users of the website. The translated content is provided directly and dynamically by Google; DoIT has no direct control over the translated content as it appears using this tool. Therefore, in all contexts, the English content, as directly provided by DoIT is to be held authoritative.


    Dispenser Updates

    ​​Naloxone Medication Data​ 

    ​In the Maryland 2022 Legislative Session, Chapter 224 "Public Health – Prescription Drug Monitoring Program (PDMP) – Naloxone Medication Data" passed.  What this means is that dispensers who currently report CDS dispenses to the PDMP will also begin reporting naloxone dispenses to the PDMP.  The bill gave the start date of October 1, 2022; however, the regulations t​o guide this change were promulgated in May 2023.  The PDMP Advisory Board has given dispensers an implementation period to operationalize the new naloxone reporting requirement until July 20, 2023.  If a prescriber writes a prescription for naloxone and does not have a DEA number, then the dispenser should provide the prescriber's NPI number.  As a reminder, these naloxone dispenses will not be viewable in the PDMP; the data will be used in aggregate for public health surveillance and planning.  Here is the updated RxGov PDMP Data Submitter ​Guide​.

    Maryland PDMP Dispenser Reporting Requirements

    Maryland's PDMP data collection vendor is NIC and the platform through which it collects data i​s RxGov.  Dispensers, or their authorized data submitter, must report data every 24 hours to RxGov to be in compliance with Maryland statute requirements, including submission of zero reports if no dispensing occurs. ‘Zero reports’ are required on any day that the dispenser does not dispense a CS prescription, regardless of whether or not the dispensing facility is open for business that day.​ 

    If you would like assistance with submitting your CS dispense da​​ta, contact the MD PDMP Help Desk by email rxgovsupport@leaporbit.com​ or call 1-844-767-4767 (24/7/365).​

     Correspondence Archive